Literature DB >> 9735673

A case of CMV disease of the jejunum in a patient with non-Hodgkin's lymphoma.

K J Han1, I S Jung, C K Kim, S K Park, D W Kim, S H Baick, J H Won, D S Hong, S D Hwang, C Moon, H S Park.   

Abstract

CMV infection may occur anywhere in the gastrointestinal tract. Among the small intestine, ileum is the most common site of CMV disease and infection of jejunum is a rare one in patients with CMV gastroenteritis. Although rare, the reason why the recognition of this diagnosis is important is that it cause the lethal hemorrhage and perforation of gastrointestinal tract when its diagnosis and treatment was delayed. Rapid diagnosis are able to using the immunohistochemical stain in shell vial culture of infected specimen or peripheral neutrophils preparation in viremic patients within 8 to 36 hours. The treatment of choice is antiviral agent or surgical resection. We experienced a case of CMV disease of jejunum in patient with non-Hodgkin's lymphoma who showed severe ulceration in jejunum and massive intestinal hemorrhage, and he survived after successful treatment with segmental resection of jejunum and intravenous ganciclovir.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735673      PMCID: PMC4531948          DOI: 10.3904/kjim.1998.13.2.143

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  15 in total

1.  Prospective study of cytomegalovirus antigenemia in allograft recipients.

Authors:  H Miller; E Rossier; R Milk; C Thomas
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Cytomegalovirus colitis. Report of the clinical, endoscopic, and pathologic findings in two patients with the acquired immune deficiency syndrome.

Authors:  M S Meiselman; J P Cello; W Margaretten
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

3.  Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation.

Authors:  K L Hinnant; H Z Rotterdam; E T Bell; M L Tapper
Journal:  Am J Gastroenterol       Date:  1986-10       Impact factor: 10.864

Review 4.  Treatment of cytomegalovirus disease.

Authors:  D Emanuel
Journal:  Semin Hematol       Date:  1990-04       Impact factor: 3.851

Review 5.  Epidemiology and pathogenesis of cytomegalovirus disease.

Authors:  J A Zaia
Journal:  Semin Hematol       Date:  1990-04       Impact factor: 3.851

6.  Perforation of the colon associated with cytomegalovirus infection.

Authors:  Z D Goodman; J K Boitnott; J H Yardley
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

7.  Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction.

Authors:  N M Jiwa; G W Van Gemert; A K Raap; F M Van de Rijke; A Mulder; P F Lens; M M Salimans; F E Zwaan; W Van Dorp; M Van der Ploeg
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

8.  Diagnosis and treatment of cytomegalovirus disease in transplant patients based on gastrointestinal tract manifestations.

Authors:  J L Mayoral; C M Loeffler; C G Fasola; M A Kramer; W J Orrom; A J Matas; J S Najarian; D L Dunn
Journal:  Arch Surg       Date:  1991-02

9.  Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients.

Authors:  A N Cheung; I O Ng
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

10.  Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodeficiency syndrome.

Authors:  A B Knapp; D A Horst; G Eliopoulos; H F Gramm; L W Gaber; K R Falchuk; Z M Falchuk; C Trey
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

View more
  2 in total

1.  Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma.

Authors:  Nicola Pyatt; Subir Mitra
Journal:  BMJ Case Rep       Date:  2012-07-05

2.  High incidence of Epstein-Barr virus, cytomegalovirus and human herpesvirus 6 infections in children with cancer.

Authors:  Jaroslav Michálek; Radek Horvath
Journal:  BMC Pediatr       Date:  2002-01-10       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.